Results 41 to 50 of about 5,289,236 (296)

Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice

open access: yesJournal of Ginseng Research, 2021
Background: Ginsenoside Rg1 (Rg1), an active ingredient in ginseng, may be a potential agent for the treatment of Alzheimer’s disease (AD). However, the protective effect of Rg1 on neurodegeneration in AD and its mechanism of action are still ...
Han Zhang   +10 more
doaj   +1 more source

Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

open access: yesRenal Failure, 2023
Diabetic kidney disease (DKD) is a severe complication of type 2 diabetes mellitus (T2DM). However, the pathogenesis of DKD remains unclear, and effective treatment strategies are still lacking. Ginsenoside Rg1 (Rg1) has been reported to improve DKD, but
Pengmin Ji   +8 more
doaj   +1 more source

Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications

open access: yesTherapeutic Advances in Endocrinology and Metabolism
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties and diverse clinical implications.
S. Alharbi
semanticscholar   +1 more source

Targeting immunometabolism as an anti-inflammatory strategy

open access: yesCell Research, 2020
The growing field of immunometabolism has taught us how metabolic cellular reactions and processes not only provide a means to generate ATP and biosynthetic precursors, but are also a way of controlling immunity and inflammation.
E. Palsson-McDermott, L. O’Neill
semanticscholar   +1 more source

The role of a key transcription factor PU.1 in autoimmune diseases

open access: yesFrontiers in Immunology, 2022
PU.1, a transcription factor member of the E26 transformation-specific family, affects the function of a variety of immune cells in several physiological and pathological conditions.
Yilong Fang   +15 more
doaj   +1 more source

The Effects of MicroRNAs on Key Signalling Pathways and Epigenetic Modification in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis

open access: yesMediators of Inflammation, 2018
MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at the posttranscriptional level via direct binding to the 3′-untranslated region (UTR) of target mRNAs.
Wenming Hong   +4 more
doaj   +1 more source

Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review

open access: yesTropical Medicine and Infectious Disease
Interleukins (ILs) are signaling molecules that are crucial in regulating immune responses during infectious diseases. Pro-inflammatory ILs contribute to the activation and recruitment of immune cells, whereas anti-inflammatory ILs help to suppress ...
A. Al-Qahtani   +2 more
semanticscholar   +1 more source

The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

open access: yesAdvances in wound care, 2020
Significance: Fibrosis is the endpoint of chronic disease in multiple organs, including the skin, heart, lungs, intestine, liver, and kidneys. Pathologic accumulation of fibrotic tissue results in a loss of structural integrity and function, with ...
Emily H. Steen   +5 more
semanticscholar   +1 more source

Long non-coding RNAs: Potential therapeutic targets for epilepsy

open access: yesFrontiers in Neuroscience, 2022
Epilepsy is a common and disastrous neurological disorder characterized by abnormal firing of neurons in the brain, affecting about 70 million people worldwide.
Sen Liu   +14 more
doaj   +1 more source

Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice

open access: yesJournal of Ginseng Research, 2023
Background: As a complication of Type II Diabetes Mellitus (T2DM), the etiology, pathogenesis, and treatment of cognitive dysfunction are still undefined.
Xianan Dong   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy